ALNY
Price
$323.19
Change
+$4.94 (+1.55%)
Updated
Jun 27 closing price
Capitalization
42.12B
32 days until earnings call
ARGX
Price
$560.14
Change
+$0.10 (+0.02%)
Updated
Jun 27 closing price
Capitalization
34.11B
32 days until earnings call
Interact to see
Advertisement

ALNY vs ARGX

Header iconALNY vs ARGX Comparison
Open Charts ALNY vs ARGXBanner chart's image
Alnylam Pharmaceuticals
Price$323.19
Change+$4.94 (+1.55%)
Volume$2.05M
Capitalization42.12B
argenx SE
Price$560.14
Change+$0.10 (+0.02%)
Volume$474.71K
Capitalization34.11B
ALNY vs ARGX Comparison Chart in %
Loading...
ALNY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
ARGX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ALNY vs. ARGX commentary
Jun 30, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ALNY is a Buy and ARGX is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Jun 30, 2025
Stock price -- (ALNY: $323.19 vs. ARGX: $560.14)
Brand notoriety: ALNY and ARGX are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ALNY: 222% vs. ARGX: 128%
Market capitalization -- ALNY: $42.12B vs. ARGX: $34.11B
ALNY [@Biotechnology] is valued at $42.12B. ARGX’s [@Biotechnology] market capitalization is $34.11B. The market cap for tickers in the [@Biotechnology] industry ranges from $299.85B to $0. The average market capitalization across the [@Biotechnology] industry is $2.3B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ALNY’s FA Score shows that 1 FA rating(s) are green whileARGX’s FA Score has 1 green FA rating(s).

  • ALNY’s FA Score: 1 green, 4 red.
  • ARGX’s FA Score: 1 green, 4 red.
According to our system of comparison, ARGX is a better buy in the long-term than ALNY.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ALNY’s TA Score shows that 4 TA indicator(s) are bullish while ARGX’s TA Score has 4 bullish TA indicator(s).

  • ALNY’s TA Score: 4 bullish, 4 bearish.
  • ARGX’s TA Score: 4 bullish, 5 bearish.
According to our system of comparison, ALNY is a better buy in the short-term than ARGX.

Price Growth

ALNY (@Biotechnology) experienced а +4.36% price change this week, while ARGX (@Biotechnology) price change was +3.32% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +4.13%. For the same industry, the average monthly price growth was +31.22%, and the average quarterly price growth was +12.91%.

Reported Earning Dates

ALNY is expected to report earnings on Jul 31, 2025.

ARGX is expected to report earnings on Jul 31, 2025.

Industries' Descriptions

@Biotechnology (+4.13% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
ALNY($42.1B) has a higher market cap than ARGX($34.1B). ALNY YTD gains are higher at: 37.346 vs. ARGX (-8.920). ARGX has higher annual earnings (EBITDA): 365M vs. ALNY (-152.58M). ARGX has more cash in the bank: 3.38B vs. ALNY (2.63B). ARGX has less debt than ALNY: ARGX (39.1M) vs ALNY (1.3B). ARGX has higher revenues than ALNY: ARGX (2.58B) vs ALNY (2.35B).
ALNYARGXALNY / ARGX
Capitalization42.1B34.1B123%
EBITDA-152.58M365M-42%
Gain YTD37.346-8.920-419%
P/E RatioN/A34.15-
Revenue2.35B2.58B91%
Total Cash2.63B3.38B78%
Total Debt1.3B39.1M3,330%
FUNDAMENTALS RATINGS
ALNY vs ARGX: Fundamental Ratings
ALNY
ARGX
OUTLOOK RATING
1..100
8857
VALUATION
overvalued / fair valued / undervalued
1..100
99
Overvalued
73
Overvalued
PROFIT vs RISK RATING
1..100
1926
SMR RATING
1..100
10050
PRICE GROWTH RATING
1..100
4158
P/E GROWTH RATING
1..100
10085
SEASONALITY SCORE
1..100
9575

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

ARGX's Valuation (73) in the Pharmaceuticals Other industry is in the same range as ALNY (99) in the Biotechnology industry. This means that ARGX’s stock grew similarly to ALNY’s over the last 12 months.

ALNY's Profit vs Risk Rating (19) in the Biotechnology industry is in the same range as ARGX (26) in the Pharmaceuticals Other industry. This means that ALNY’s stock grew similarly to ARGX’s over the last 12 months.

ARGX's SMR Rating (50) in the Pharmaceuticals Other industry is somewhat better than the same rating for ALNY (100) in the Biotechnology industry. This means that ARGX’s stock grew somewhat faster than ALNY’s over the last 12 months.

ALNY's Price Growth Rating (41) in the Biotechnology industry is in the same range as ARGX (58) in the Pharmaceuticals Other industry. This means that ALNY’s stock grew similarly to ARGX’s over the last 12 months.

ARGX's P/E Growth Rating (85) in the Pharmaceuticals Other industry is in the same range as ALNY (100) in the Biotechnology industry. This means that ARGX’s stock grew similarly to ALNY’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
ALNYARGX
RSI
ODDS (%)
Bearish Trend 3 days ago
73%
Bullish Trend 3 days ago
70%
Stochastic
ODDS (%)
Bearish Trend 3 days ago
75%
Bullish Trend 3 days ago
74%
Momentum
ODDS (%)
N/A
Bearish Trend 3 days ago
63%
MACD
ODDS (%)
Bullish Trend 3 days ago
72%
Bullish Trend 3 days ago
80%
TrendWeek
ODDS (%)
Bullish Trend 3 days ago
70%
Bullish Trend 3 days ago
67%
TrendMonth
ODDS (%)
Bullish Trend 3 days ago
72%
Bearish Trend 3 days ago
66%
Advances
ODDS (%)
Bullish Trend 14 days ago
75%
N/A
Declines
ODDS (%)
Bearish Trend 4 days ago
66%
Bearish Trend 4 days ago
63%
BollingerBands
ODDS (%)
Bearish Trend 3 days ago
87%
Bullish Trend 3 days ago
74%
Aroon
ODDS (%)
Bullish Trend 3 days ago
76%
Bearish Trend 3 days ago
71%
View a ticker or compare two or three
Interact to see
Advertisement
ALNY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
ARGX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
BTO35.050.72
+2.10%
John Hancock Financial Opportunities Fund
BKCI51.170.44
+0.87%
BNY Mellon Concentrated Internatnl ETF
KAUG24.82-0.01
-0.05%
Innovator U.S. Small Cp Pwr Buf ETF -Aug
MEM32.52-0.09
-0.26%
Matthews Emerging Markets Eq Actv ETF
PHYS25.01-0.46
-1.81%
Sprott Physical Gold Trust

ALNY and

Correlation & Price change

A.I.dvisor indicates that over the last year, ALNY has been loosely correlated with IONS. These tickers have moved in lockstep 57% of the time. This A.I.-generated data suggests there is some statistical probability that if ALNY jumps, then IONS could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ALNY
1D Price
Change %
ALNY100%
+1.55%
IONS - ALNY
57%
Loosely correlated
N/A
ARGX - ALNY
50%
Loosely correlated
+0.02%
REGN - ALNY
35%
Loosely correlated
N/A
RARE - ALNY
35%
Loosely correlated
-2.43%
GOSS - ALNY
34%
Loosely correlated
-3.85%
More

ARGX and

Correlation & Price change

A.I.dvisor indicates that over the last year, ARGX has been loosely correlated with ALNY. These tickers have moved in lockstep 50% of the time. This A.I.-generated data suggests there is some statistical probability that if ARGX jumps, then ALNY could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ARGX
1D Price
Change %
ARGX100%
+0.02%
ALNY - ARGX
50%
Loosely correlated
+1.55%
IONS - ARGX
45%
Loosely correlated
N/A
MTVA - ARGX
43%
Loosely correlated
-7.35%
ROIV - ARGX
43%
Loosely correlated
-1.81%
BLUE - ARGX
40%
Loosely correlated
N/A
More